近端小型及微小增生性息肉患者同步进展期肿瘤发生率高于无锯齿状病变患者
在2005至2010年某学术医疗中心的连续筛查结肠镜队列中,近端小型增生性息肉(HP)患者同步进展期肿瘤发生率为12.7%(61/482),高于无任何近端HP或无蒂锯齿状息肉(SSP)患者的7.1%(133/1878),差异有统计学意义(P < .001)。近端微小(≤5 mm)HP患者的同步进展期肿瘤发生率(12.6%,51/404)与近端微小SSP患者(15.0%,17/113)无显著差异(P = .529)。
要点
- 近端小型HP患者同步进展期肿瘤发生率12.7%,高于无锯齿状病变者的7.1%(P < .001)。
- 近端微小HP(≤5 mm)与近端微小SSP的同步进展期肿瘤发生率无显著差异(12.6% vs 15.0%,P = .529)。
- 近端小型HP按大小分层(≤5 mm vs 6-9 mm)的同步进展期肿瘤发生率无显著差异(P = 1.00)。
核心结论
- 近端小型及微小HP患者较筛查结肠镜未检出任何锯齿状病变者似乎有更高的同步进展期肿瘤发生率。
- 近端小型HP患者异时性进展期肿瘤的监测结局值得进一步研究。
- 近端微小HP的同步进展期肿瘤发生率与近端微小SSP相似,可能对「切除并丢弃」策略有启示。
研究设计与样本
- 2005至2010年某学术医疗中心的连续筛查结肠镜队列。
- 共2569例患者,分为3个互斥组:组1为至少1枚位于乙状结肠近端、内镜尺寸<1 cm、总数不超过3枚的HP(482/2569,18.8%);组2为无任何近端HP或SSP(1878例);组3为1至2枚SSP、至少1枚位于乙状结肠近端、内镜尺寸<1 cm且无异型增生(113例)。
- 比较近端小型(<1 cm)及微小(≤5 mm)HP患者与其他两组同步进展期肿瘤的发生率。
主要发现
- 近端小型HP患者同步进展期肿瘤发生率为12.7%(61/482),高于无锯齿状病变组(组2)的7.1%(133/1878),P < .001。
- 近端小型HP按大小分层:≤5 mm组为12.6%(51/404),6-9 mm组为12.8%(10/78),两组无显著差异(P = 1.00)。
- 近端微小(≤5 mm)HP患者同步进展期肿瘤发生率为12.6%(51/404),与近端微小SSP患者的15.0%(17/113)无显著差异(P = .529)。
关键数值与推荐
- 美国多学会结直肠癌工作组目前不推荐在检出近端小型HP时改变监测间隔。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The association of proximal small and diminutive hyperplastic polyps (HPs) with synchronous advanced neoplasia is not well-defined. However, sessile serrated polyps (SSPs), even when small, are known to portend a risk of synchronous neoplasia. Currently, the U.S. Multi-Society Task Force on Colorectal Cancer does not recommend a change in the surveillance interval when proximal small HPs are detected. We aimed to compare the rates of synchronous advanced neoplasia in a screening colonoscopy cohort of patients with small and then diminutive proximal HPs in comparison, first to a cohort absent any serrated or proximal HPs and then in comparison with a cohort with small proximal SSPs. METHODS: Consecutive screening colonoscopies were recorded between 2005 and 2010 at an academic medical center. Patients were divided into 3 mutually exclusive groups. Group 1 consisted of patients with at least 1 HP that was proximal to the sigmoid colon, <1 cm in endoscopic size, and up to 3 total HPs in number. Group 2 included patients without any proximal HPs or SSPs. Group 3 consisted of patients with 1 to 2 SSPs, with at least 1 being proximal to the sigmoid colon, that were <1 cm in endoscopic size and without dysplasia. Rates of synchronous advanced neoplasia in patients with small (<1 cm) and diminutive (≤5 mm) proximal HPs were compared with the rates for the other 2 groups. RESULTS: There were 482 of 2569 patients (18.8%) with a small proximal HP who met the criteria for Group 1. The rate of synchronous advanced neoplasia in patients with a small proximal HP (61/482, 12.7%) was significantly greater compared with the average risk in the non-serrated cohort (Group 2, 133/1878, 7.1%; P < .001). There was no significant difference in the rate of synchronous advanced neoplasia when the small proximal HP group was subdivided by size (≤5 mm, 51/404, 12.6% vs 6-9 mm, 10/78, 12.8%; P = 1.00). The rate of synchronous advanced neoplasia in patients with diminutive (≤5 mm) proximal HPs (51/404, 12.6%) was not significantly different from the rate observed with proximal SSPs of similar size (17/113, 15.0%; P = .529). CONCLUSION: Patients with small and diminutive proximal HPs tend to harbor higher rates of synchronous advanced neoplasia compared with those without any serrated lesions detected on screening colonoscopy. Surveillance outcomes for metachronous advanced neoplasia for patients with small proximal HPs deserves further study. The synchronous advanced neoplasia rate in patients with proximal diminutive HPs is similar to that of proximal diminutive SSPs and could have implications in a resect and discard strategy.
引用
- Hamoudah T, Ma K, Esteban M, et al. Patients with small and diminutive proximal hyperplastic polyps have higher rates of synchronous advanced neoplasia compared with patients without serrated lesions. Gastrointest Endosc. 2018. PMID: 29337039. doi:10.1016/j.gie.2017.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。